Skip to content

Integra LifeSciences IART Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin50.9%-3.9pp54.8%-2.6pp57.4%-4.9pp62.3%+1.0pp
Operating margin-31.6%-33.3pp1.8%-5.5pp7.2%-8.1pp15.3%+2.6pp
Net margin-31.6%4.4%-7.2pp11.6%+0.6pp
Returns
Return on equity-39.9%4%-6.4pp10.3%-0.2pp
Return on invested capital-17.6%-18.7pp1%-3.0pp4.1%-5.2pp9.3%+1.8pp
Efficiency
Asset turnover0.4×0.0×0.4×0.0×0.4×0.0×0.4×0.0×
Liquidity
Current ratio2.5×+1.4×1.2×-2.3×3.4×-0.2×3.6×+0.2×
Leverage
Debt-to-equity1.8×+0.6×1.2×+0.6×0.6×+0.1×0.5×0.0×
Per Share
Book value per share$13.61-32.2%$20.07+1.5%$19.77-8.5%$21.61+9.6%
Valuation
Market capitalization$1.38B+53.4%$1.75B-48.7%$3.41B-27.2%$4.68B-17.5%
Price / sales0.8×+0.3×1.1×-1.1×2.2×-0.8×-0.7×
Price / book1.3×+0.7×1.1×-1.0×2.1×-0.4×2.6×-0.8×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Integra LifeSciences's profit margins?
Integra LifeSciences (IART) runs a 51.9% gross margin and a -29.8% operating margin, with a -30.1% net margin.
Where do Integra LifeSciences's ratios come from?
Every ratio is computed from Integra LifeSciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.